Cosway Company, Inc. – FDA 483, Oct 27, 2023
Cosway Company, Inc. in Carson, CA, a contract manufacturer of OTC drug products, was cited for significant deficiencies during an FDA inspection. Observations included a lack of appropriate controls over computer systems, specifically an unvalidated Excel spreadsheet used for stability data without an audit trail or proper security. Additionally, the firm failed to thoroughly investigate out-of-specification temperature and humidity readings for stability chambers used in OTC drug product stability studies.
ID · 7e6674ce-c701-4bb4-820b-72f144a37352
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.